AGE

, Volume 20, Issue 3, pp 165–168 | Cite as

Effects of the antioxidant turmeric on lipoprotein peroxides: Implications for the prevention of atherosclerosis

  • A. Ramirez Bosca
  • M. A. Carrión Gutierrez
  • A. Soler
  • C. Puerta
  • A. Diez
  • E. Quintanilla
  • A. Bernd
  • J. Miquel

Abstract

Extracts from the rhyzome of Curcuma longa are widely used as food additives in India and other Asiatic and Central American countries. It has been shown that these extracts (“turmeric”), as well as “curcumin” and related phenolic compounds isolated from Curcuma, have a powerful antioxidant action when tested in in vitro systems. Moreover, previous research from our laboratories has shown significant decreases in the levels of lipid peroxides in the blood of both mice and human subjects administered “turmeric.” Our present research complements the previous data, showing that a daily intake of turmeric equivalent to 20 mg of the phenolic antioxidant curcumin for 60 days decreases the high levels of peroxidation of both the HDL and the LDL, in vivo, in 30 healthy volunteers ranging in age from 40 to 90 years. The effect was quite striking in the persons with high baseline values of peroxidized compounds in these lipoproteins, while no apparent change took place in the persons having low baseline values.

In view of current concepts on the atherogenic role played by peroxidized HDL, and especially by peroxidized LDL, as inducers of foam and smooth cell proliferation in the arterial wall, this preliminary experiment suggests that the Curcuma phenolic antioxidants, because of their high antioxidant activity and lack of toxicity, might be a useful complement to standard hypo-lipidemic drugs in the prevention and treatment of atherosclerosis.

Keywords

Atherosclerosis atherogenesis lipoperoxides LDL turmeric curcuma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cummins, E.M., Hayward, M.D., and Saito, S.: Differentials in active life expectancy in the older population of the United States. J. Gerontol., Social Sciences, 51B: S111–120, 1996.Google Scholar
  2. 2.
    Harman, D.: Aging: a theory based on free radical and radiation chemistry. J. Gerontol., 11: 298–300, 1956.PubMedGoogle Scholar
  3. 3.
    Harman, D.: Free radical theory of aging: role of free radicals in the origination and evolution of life, aging and disease processes, in Free Radicals, Aging and Degenerative Diseases, edited by Johnson, J. E., Jr., Walford, R, Harman, D. and Miquel, J., New York, Alan R Liss, 1986, pp. 3–49.Google Scholar
  4. 4.
    Zs.-Nagy, I.: A membrane hypothesis of aging. J. Theoret. Biol., 75: 189–195, 1978.CrossRefGoogle Scholar
  5. 5.
    Harman, D.: The biological clock: the mitochondria? J. Am. Geriatr. Soc. 20: 145–147, 1972.PubMedGoogle Scholar
  6. 6.
    Miquel, J., Economos A.C., Fleming, J., Bensch, K.G., Atlan, H. and Johnson J.E. Jr.: Mitochondrial role in cell aging. Exptl. Gerontol., 15: 575–591, 1980.CrossRefGoogle Scholar
  7. 7.
    Fleming, J.E., Miquel, J., Cottrell, L.S., and Yengoyan L.S.: Is cell aging caused by respiration-dependent injury to the mitochondrial genome? Gerontology 28: 44–53, 1982.PubMedCrossRefGoogle Scholar
  8. 8.
    Miquel, J.: An update on the mitochondrial-DNA mutation hypothesis of cell aging. Mutation Res., 275: 209–216, 1992.CrossRefPubMedGoogle Scholar
  9. 9.
    Harman, D.: Free radical theory of aging: nutritional implications. Age 1: 145–152, 1978.CrossRefGoogle Scholar
  10. 10.
    Weber, H. and Miquel, J.: Antioxidant supplementation and longevity. In Nutritional Aspects of Aging, edited by Chen, L., Boca Raton, CRC Press, Vol. 1, 1986, pp. 42–49.Google Scholar
  11. 11.
    De la Fuente, M., Ferrandez, D., Muñoz, F., De Juan, E. and Miquel, J.: Stimulation by the antioxidant thioproline of the lymphocyte functions of old mice. Mech. Ageing Dev. 68: 27–36, 1993.CrossRefPubMedGoogle Scholar
  12. 12.
    Miquel, J., Martínez, M., Diez, A., De Juan, E., Soler, A., Ramirez, A., Laborda, J. and Carrión, M.: Effects of turmeric on blood and liver lipoperoxide levels of mice: lack of toxicity. Age 18: 171–174, 1995.Google Scholar
  13. 13.
    Ramirez-Boscá, A., Soler, A., Carrión Gutiérrez, M.A., Laborda Alvarez, A. and Quintanilla Almagro, E.: Antioxidant curcuma extracts decrease the blood lipid peroxide levels of human subjects. Age 18: 167–169, 1995.Google Scholar
  14. 14.
    Azuine, M.A. and Bhide S.V.: Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr. Cancer 17: 77–83, 1992.PubMedCrossRefGoogle Scholar
  15. 15.
    Soni K.B., Rajan, A. and Juttan, R.: Reversal of aflatoxin-induced liver damage by turmeric and curcumin. Cancer Letters 66: 115–121, 1992.CrossRefPubMedGoogle Scholar
  16. 16.
    Toda, S: Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma Longa L. Chem. Pharm. Bull. 33: 1725–1728, 1985.PubMedGoogle Scholar
  17. 17.
    Masuda, T., Isobe, J., Jitoe, A. and Nakatani, N.: Antioxidative curcuminoids from rhizomes of Curcuma xantorrhyza. Phytochemistry 31: 3645–3647, 1992.CrossRefGoogle Scholar
  18. 18.
    Jitoe, A., Masuda, T., Tengah, I.G.P., Suprapta, D.N., Gara, I.W. and Nakatani, N: Antioxidant activity of tropical ginger extracts and analysis of the contained curcuminoids. J. Agrc. Food Chem. 40: 1337–1340, 1992.CrossRefGoogle Scholar
  19. 19.
    Sharma, O.P.: Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol., 25: 1811–1812, 1976.CrossRefPubMedGoogle Scholar
  20. 20.
    Henning, B. and Chow, C.K.: Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Rad. Biol. Med. 4: 99–106, 1988.CrossRefGoogle Scholar
  21. 21.
    Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990’s. Nature 362: 801–809, 1993.CrossRefPubMedGoogle Scholar
  22. 22.
    Povear, H., Santos, C., Gammaro, R., Camara, M., and Oliveira Lima, A.: Peroxidized LDL: a new risk factor in atherosclerosis. Presented at the “International Congress on Free Radicals and Aging,” Paris, 26–28 September 1991.Google Scholar
  23. 23.
    Ohkava, M., Ohishi, N., and Yagi; K.: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351–358, 1979.CrossRefGoogle Scholar
  24. 24.
    Harman, D.: Atherosclerosis: oxidation of serum lipoproteins and its relationship to pathogenesis. Clin Res. 8: 108, 1960.Google Scholar
  25. 25.
    Yagi, K., Ohkawa, H., Ohishi, N., Yamashita, M., and Nakashima, T.: Lesion of aortic intima caused by intravenous administration of linoleic acid hydroperoxide. J. Appl. Biochem. 3: 58–67, 1981.Google Scholar
  26. 26.
    Yagi, K.: Serum lipid peroxide levels in subjects having certain diseases and aging. In CRC Handbook of Free Radicals and Antioxidants in Biomedicine, Vol. 1, edited by Miquel, J., Quintanilha, A. and Weber, H., Boca Ratón, CRC Press, 1989, pp. 223–230.Google Scholar
  27. 27.
    Santos, M. T., Valles, J. and Aznar, J.: Plasma lipid peroxides in patients with vascular disease and in middle-aged normal subjects with a high risk of atherosclerosis. In CRC Handbook of Free Radicals and Antioxidants in Biomedicine, edited by Miquel, J., Quintanilha, A. and Weber, H., Boca Raton, CRC Press, 1989, pp. 237–254.Google Scholar
  28. 28.
    Mitchinson, M.J.: Macrophages, oxidized lipids and atherosclerosis. Med. Hypotheses 12: 171–178, 1983.CrossRefPubMedGoogle Scholar
  29. 29.
    Carpenter, K.L.H., Wilkins, G.M. and Fussele, B.: Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochem. J. 304: 625–633, 1994.PubMedGoogle Scholar
  30. 30.
    Holvoet, P. and Collen, D.: Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 8: 1279–1284, 1994.PubMedGoogle Scholar
  31. 31.
    Johnson, E.J.: Aging and carotene nutriture. Age 16: 59–66, 1993.Google Scholar
  32. 32.
    Rimm, E.B.: Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328: 1450–1456, 1993.CrossRefPubMedGoogle Scholar
  33. 33.
    Stephens, N.G., Parsons, A., Schofield, P.M., Kelly, F., Cheeseman, K., Mitchinson, M.J.: Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). The Lancet 347: 781–786, 1996.CrossRefGoogle Scholar
  34. 34.
    Faramarz, A., Suzuki, S., Hua-Zhou, J., Isshiki, N., and Miyachi, Y.: Involvement of lipid peroxidation in necrosis of skin flaps and its suppression by ellagic acid. Plast. Reconstr. Surg. 94: 1027–1035, 1994.CrossRefGoogle Scholar

Copyright information

© American Aging Association, Inc. 1997

Authors and Affiliations

  • A. Ramirez Bosca
    • 1
  • M. A. Carrión Gutierrez
    • 1
  • A. Soler
    • 2
  • C. Puerta
    • 3
  • A. Diez
    • 4
  • E. Quintanilla
    • 1
  • A. Bernd
    • 5
  • J. Miquel
    • 4
    • 6
  1. 1.A.S.A.C. Pharmaceutical International, A.I.E.AlicanteSpain
  2. 2.Ibermútua, AlicanteSpain
  3. 3.Hogar Provincial, AlicanteSpain
  4. 4.Department of Pharmacology and TherapeuticsSchool of Medicine, University of AlicanteSpain
  5. 5.Dpt. of DermatologyJ.W. Goethe U. FrankfurtGermany
  6. 6.Farmacologia, Facultad de MedicinaSan Juan-AlicanteSpain

Personalised recommendations